Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2000
10/19/2000DE19916460A1 New heterocyclyl-benzimidazole carboxamide derivatives, useful for treating e.g. neurodegenerative diseases, epilepsy, ischemic damage, myocardial infarction, tumors, inflammation and diabetes
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2370406A1 Pharmaceutical compounds
10/19/2000CA2369728A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2368830A1 Prodrugs of thrombin inhibitors
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044967A2 2-Pyridinylguanidine urokinase inhibitors
10/18/2000EP1044198A1 Morpholino end-capped, hindered amine substituted aminotriazine and their use as light stabilizers
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044191A2 Benzylidene pyrazolones, production and use thereof
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP1043999A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP1043977A1 Oral pharmaceutical pulsed release dosage form
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/18/2000EP0603251B1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions
10/18/2000CN1270583A Substituted phenyluracils
10/18/2000CN1270581A 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
10/18/2000CN1270528A Nootropic agent
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/17/2000US6133456 Dimers of the macrocyclic natural product, fk506, covalently attached to each other via a synthetic linker moiety
10/17/2000US6133449 Processes and intermediates for the preparation of piperazine derivatives
10/17/2000US6133443 Optically active 1,4-dihydropyridine derivatives and process for the preparation thereof
10/17/2000US6133432 Processes for preparing pesticidal intermediates
10/17/2000US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
10/17/2000US6133303 Various indene derivatives, with the exception of 5-(2-imidazole-1-yl-ethoxy)indan-1-one; treating cancer and treating or preventing restenosis or atherosclerosis
10/17/2000US6133296 Substituted pyridyl keto enols
10/17/2000US6133291 3-(piperidin-1-ylalkylene)imidazole derivatives; glaucoma, antiallergens; antiinflammation and hypotensive agents, sleeping disorders; hypermotility of the gastrointestinal tract, alzheimer's disease, schizophrenia and
10/17/2000US6133290 Derivatives of 3-piperidin-4-yl-1h-indazolines; inhibit peptide extravasation due to stimulation of the trigeminal ganglia; treatment of migraines and associated disorders
10/17/2000US6133287 Piperidine-indole compounds having 5-HT6 affinity
10/17/2000US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133275 3-phenylpyrrolidine alpha-1 adrenergic compounds
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6133253 3-Pyridyl enantiomers and their use as analgesics
10/17/2000US6132771 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
10/17/2000US6132640 Quinoline derivative and use of same
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2202031C Condensed indan derivatives and salts thereof
10/17/2000CA2114300C Quinoline or quinazoline derivatives, their production and use
10/17/2000CA2022484C 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/15/2000CA2305940A1 Aminotriazol compounds, the process for preparing them and the pharmaceutical compositions containing them
10/13/2000CA2305047A1 2-pyridinylguanidine urokinase inhibitors
10/12/2000WO2000060044A1 Composition and method for bleaching a substrate
10/12/2000WO2000060043A1 Composition and method for bleaching a substrate
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059895A1 Pesticidal tetrazole derivatives
10/12/2000WO2000059890A1 Tetrahydropyridazine derivatives
10/12/2000WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059883A2 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059498A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059497A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059304A1 Compositions and methods for preventing and treating sexual dysfunctions
10/12/2000WO2000059285A2 NOVEL LACTAM INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
10/12/2000DE19915365A1 Tetrahydropyridazin-Derivate Tetrahydropyridazine derivatives
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors
10/12/2000CA2369541A1 Pesticidal tetrazole derivatives
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2368703A1 Substituted aniline compounds
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2364605A1 Composition and method for bleaching a substrate
10/12/2000CA2361848A1 Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000CA2360923A1 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043317A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043314A1 Novel dihydropyridine derivative
10/11/2000EP1042356A2 Intermediates and process for the synthesis of 17-unsubstituted 16.beta.-aryloxy 4-azasteroids
10/11/2000EP1042320A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
10/11/2000EP1042316A1 Indole derivatives useful a.o. for the treatment of osteoporosis
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042300A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
10/11/2000EP1042299A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
1 ... 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 ... 1080